Top Markets
Coin of the day
Pharmala Biotech Holdings Inc. Pharmala Biotech Holdings Inc.

Pharmala Biotech Holdings Inc.

MDMA
Rank in Stocks #30976
Pharmala Biotech Holdings Inc., operating as PharmAla, concentrates its efforts... Pharmala Biotech Holdings Inc., operating as PharmAla, concentrates its efforts on the research, manufacturing, and bringing to market of active pharmaceutical ingredients (APIs) within the substituted methylenedioxy-phenethylamine (MDXX) class. The company's offerings further extend to various MDXX class compounds, such as 1,3-Benzodioxolyl-Nmethylbutanamine (MBDB) and 3,4-Methylenedioxy-N-ethylamphetamine (MDEA/MDE), in addition to prepared formulations of these MDXX substances. The enterprise maintains its primary corporate offices in Vancouver, Canada.
Share Price
$0.13577832
Market Cap
$14.83M
Change (1 day)
-2.63%
Change (1 year)
44.13%
Country
CA
Trade Pharmala Biotech Holdings Inc. (MDMA)

Category

Dividend history for Pharmala Biotech Holdings Inc. (MDMA)
Pharmala Biotech Holdings Inc. (stock symbol: MDMA) made a total of 0 dividend payments.
The sum of all dividends (adjusted for stock splits) is : 0.00
Dividend yield (TTM) : 0
Dividend payments for Pharmala Biotech Holdings Inc. (MDMA) from 2026 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
Not enough data for the provided dates.
List of all dividend payments
Year Dividend Change
Not enough data for the provided dates.
Dividend payments for similar companies or competitors
Company Number of dividend payments Country
0.00%
US
0.00%
NL
64.00%
AU
0.00%
CH
29.00%
BE